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Diabetic mastopathy (DMP) is a rare fibrotic disease of the mammary gland (less than 1 % 
among benign diseases). It was first described in 1984 by Soler & Khardori in women who 
have suffered from type 1 diabetes mellitus for a long time. Clinically, DMP can manifest as 
single or double-sided, palpable, movable, painless seals. Often, DMP is a random finding 
in a mammographic examination of asymptomatic patients. At the same time, radiological 
signs are more often non-specific. When ultrasound examination of the mammary gland with 
DMP can be visualized hypoechoic formations with fuzzy, uneven contours, heterogeneous 
structure. Clinical, ultrasound and radiological manifestations of DMP are often associated by 
specialists with malignancy, which leads to unnecessary invasive procedures. In this regard, 
of interest is the clinical case of DMP in a woman of reproductive age with type 1 diabetes, 
repeated trepanobiopsy of the breast. The described clinical observation represents the case 
of repeated invasive intervention, which proves the connection between the long-term de-
compensation of type 1 diabetes that occurred in the juvenile age and the progression of the 
pathological process in the mammary glands under hyperglycemia.
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Diabetic mastopathy (DMP) is a rare fibrotic breast disease, the frequency of which 
is less than 1 % among benign organ lesions [1–3]. Was first described in 1984 godu Soler 
& Khardori [4] in women who have for a long time suffered from type 1 diabetes mel-
litus (DM) [2; 3; 5–9]. More recent studies [10; 11] have found that DMP is also associ-
ated with type 2 diabetes. In most cases, patients with diabetes have DMP complications 
(retinopathy, nephropathy or polyneuropathy) [12]. It is believed that the development 
of the disease is most likely in patients with a debut DM in juvenile age and prolonged 
hyperglycemia.
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Clinically, the DMP is often manifested in the form of single or double sided movable 
palpable, painless seals [1]. Often DMP is a random finding on mammography screening 
in asymptomatic patients.  In this case, radiographic signs often are nonspecific (mam-
mary gland with heterogeneous density, asymmetrical).
An ultrasound breast study with DMP can be visualized hypoechoic formation with 
indistinct, irregular contours, inhomogeneous structure [3; 13; 14], which often mimics a 
malignant tumor.
Histological examination of breast tissue during the DMP is represented as kelloydny 
fibrosis, lymphocytic and lobulita duktita, lymphocytic vasculitis the presence of epithe-
lioid fibroblasts and lymphocytic infiltration predominant stromal breast B cells [5; 15].
Thus, the clinical and radiographic manifestations DMP specialists often associated 
with malignancy, which leads to unnecessary invasive procedures.
In this regard, it is interesting clinical case of DMP in women of reproductive age with 
type 1 diabetes, multiple biopsy of the breast.
Patient M. 27 years since the debut of type 1 diabetes in the juvenile age and periods 
of prolonged hyperglycemia. Of the complications of diabetes — proliferative retinopathy 
(twofold laser coagulation of the retina). The menstrual cycle is not broken, menarche at 
12 years of menstruation for 6 days in a 28–30, moderate, painless. There was no preg-
nancy history.
From history we found that within 2 years, notes the appearance of painless seals in 
both breasts, discharge from the nipple was not.
Ultrasound examination of mammary glands on day 7 of the menstrual cycle fat layer 
premamarnoy expressed slightly reduced fibroglandulyarnaya tissue echogenicity, thick-
ness 23.7 mm. Ducts are not expanded. In both breasts were revealed formation of irregu-
lar hypoechoic, with fuzzy edges, dimensions 32 × 18 mm (right) and 39 × 16 mm (left). 
These areas were avascular character at Doppler study. Ultrasound examination in line 
with BI-RADS category 4, which was the reason for excisional biopsy both breasts. On 
histological examination revealed: kelloydny fibrosis.
Over the next two years, the patient was no compensation for optimum control and 
inherent glikemichesogo diabetes metabolic disorders (HbA1C — 8.4 %). After 2 years at 
the next ultrasound in both breasts have been re-defined hypoechoic focal masses up to 
50 mm in diameter, with indistinct contours. The patient was repeatedly performed exci-
sional biopsy which revealed lymphocytic ucts and sclerosing lobulit with nonprolifera-
tive fibrocystic changes. At the time of re-biopsy of breast HbA1C — 9 %.
Ultrasound examination of mammary glands on day 7  of the menstrual cycle fat 
layer premamarnoy expressed slightly reduced fibroglandulyarnaya tissue echogenicity, 
19.5 mm thick. Ducts are not expanded. The right breast in an upper-outer quadrant in 
place palpable seal  — hypoechogenic extensive portion with indistinct, irregular con-
tours, dimensions of 40 × 20 mm without duktektazii, avuskulyarny with Doppler. Type 
of ACR: D.
When elastography has been defined with a predominance of type 2 elastic areas of 
green with elements of solid blue areas mapping (Fig. 1 and Fig. 2), deformation coefficient 
1.8 (benign process). Regional lymph nodes were not detected. Conclusion: BI-RADS 3.
Thus, the described clinical observation is the case of repeated invasive interven-
tion proves communication decompensation long type 1 diabetes arising in yuvinilnom 
age and progression of pathological processes in the mammary glands under conditions 
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of hyperglycaemia. It is assumed that an important role in the genesis of this disease 
has a prolonged hyperglycemia during decompensated diabetes [15]. Thus, the hyper-
glycemic state leads to excess glycosylating proteins by addition of glucose to the amino 
group of lysine. This process, in turn, leads to the accumulation of glycosylation end 
products which are capable of irreversibly binding to proteins including collagen, the 
latter acquires a resistance to the action of endogenous kollogenaz that provide updated 
fabrics and leads to loss of elasticity. An excess concentration of such complexes is ac-
Fig. 1. Elastogram BI-RADS 3
Fig. 2. Elastogram BI-RADS 3
6 Вестник СПбГУ. Медицина. 2020. Т. 15. Вып. 1
companied by increased permeability of the vessel wall, accumulation of matrix in the 
extravascular glycated albumin, glycated glycosylated immunoglobulins and immune 
complexes. The accumulation of the past are perceived by the body as a kind of “neoan-
tigen”. This triggers a cascade of autoimmune reaction with proliferation of B cells and 
formation of autoantibodies. Subsequent macrophage-mediated removal of advanced 
glycosylation end product and can cause the release of cytokines further accumulation 
of extracellular matrix and collagen proliferation, which in turn leads to the formation 
of connective tissue [2; 3; 15] (Fig. 3).
This case also finds difficulty DMP differential diagnosis of breast cancer and, due 
to the uniformity of clinical and sonographic symptoms (Table). However, it is worth 
noting the importance of doppler in the diagnosis of DMP. It is known that in color 
Doppler mapping around and inside the cancer fails to identify a larger number of ves-
sels as compared to the benign process, which may help in differential diagnosis of 
breast pathology.
Also in the differential diagnosis between benign and malignant formation can help 
sonoelastography. It is known that malignant tumors are characterized by 4 or 5 elasto-
gram type, with a deformation ratio of 4.8, while as benign processes have a deformation 
coefficient less than 4.8 and the first, second or third elastotipy.
As there is no standard protocol is now for long-term monitoring of patients with 
DMP. Usually — the annual examination in cases where there are doubts in relation to the 
progression of, or change in the nature of lesions, can be performed cytological aspiration 
cytology or excisional biopsy. However, one should not forget that the frequency reported 
in the literature is 42–80 % relapse within 5 years after the excisional biopsy. [6], which 
Fig. 3. The hypothesis of the pathogenesis of DMP
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happened in the illustrated clinical case. These relapses are usually bilateral and more ex-
tensive, which leads to the dilemma of the tactics of these patients [13].
Table. Comparative characteristics of the DMP and breast cancer
Sign DMP Breast cancer








tumor contours rough, fuzzy rough, fuzzy
tumor structure inhomogeneous inhomogeneous
doppler no increase vascularization increased vascularization
sonoelastography 1, 2, 3 elastotype 4, 5 elastotype
From the above it follows that patients with type 1 diabetes which has arisen in ju-
venile age, with prolonged hyperglycemic states are at risk of developing DMP. There is 
urgency to further explore the features of this disease for timely accurate diagnosis, which 
can help women avoid repeated biopsies and surgeries.
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